S-8

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM S-8

REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933

MEDTRONIC, INC.

(Exact name of registrant as specified in its charter)

Minnesota
(State or other jurisdiction of
incorporation or organization) 41-0793183
(I.R.S. Employer
Identification Number)

World Headquarters
710 Medtronic Parkway
Minneapolis, Minnesota 55432

(Address, including zip code, of Principal Executive Offices)

Medtronic, Inc. 2008 Stock Award and Incentive Plan

(Full title of the Plan)

James Nathan Spolar, Esq.
Principal Legal Counsel and Assistant Secretary
Medtronic, Inc.; World Headquarters
710 Medtronic Parkway
Minneapolis, Minnesota 55432
Telephone: (763) 514-4000
(Name, address and telephone number,
including area code, of agent for service)

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer þ Accelerated filer o Non-accelerated filer o (Do not check if a smaller reporting company) Smaller reporting company o

CALCULATION OF REGISTRATION FEE

		Proposed
		Maximum
Title of Securities to be	Amount to Be	Offering Price	Proposed Maximum	Amount of
registered	Registered(1)	Per Share(2)	Aggregate Offering Price(2)	Registration Fee(2)
Common Stock, $0.10 par value per share, together with the associated Preferred Stock Purchase Rights	50,000,000	$37.05	$1,852,500,000	$103,370

(1)

This amount represents a 50,000,000 share increase in the number of shares of common stock, par value $0.10 per share, of the Registrant (the “Common Stock”) authorized for issuance under the Medtronic, Inc. 2008 Stock Award and Incentive Plan (the “Plan”) (As amended and restated effective August 27, 2009), including, pursuant to Rule 416 under the Securities Act of 1933, an indeterminate number of additional shares that may become issuable in accordance with the adjustment and anti-dilution provisions of such plan.

(2)

Estimated solely for the purpose of determining the registration fee pursuant to Rule 457(h), based on the average of the high and low sales prices of the Common Stock as reported on the New York Stock Exchange on October 13, 2009.

TABLE OF CONTENTS

PART II INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
	Item 3 Incorporation of Documents by Reference
	Item 8 Exhibits
SIGNATURES
EXHIBIT INDEX
EX-5.1
EX-23.2
EX-24.1

EXPLANATORY NOTE

     A Registration Statement was filed on September 23, 2008 (Registration No. 333-153636) (the “Prior Registration Statement”), to register under the Securities Act of 1933, among other things, shares of Medtronic, Inc. common stock, par value $0.10 per share (the “Common Stock”), issuable under the Medtronic, Inc. 2008 Stock Award and Incentive Plan (the “Plan”) (As amended and restated effective August 27, 2009). This Registration Statement has been prepared and filed pursuant to and in accordance with the requirements of General Instruction E to Form S-8 for the purpose of effecting the registration under the Securities Act of 1933 of an additional 50,000,000 shares of Common Stock that are issuable under the Plan at any time or from time to time.

STATEMENT OF INCORPORATION BY REFERENCE

     Pursuant to General Instruction E to Form S-8, Medtronic hereby incorporates by reference the contents of the Prior Registration Statement to the extent not otherwise amended or superseded by the contents hereof.

PART II INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

Item 3. Incorporation of Documents by Reference

     The following documents filed with (excluding documents furnished to) the Securities and Exchange Commission (the “Commission”) pursuant to the Securities Exchange Act of 1934, as amended (the “Exchange Act”) are hereby incorporated by reference into this Registration Statement:

     (1) Medtronic’s Annual Report on Form 10-K, for the fiscal year ended April 24, 2009, filed with the Commission on June 23, 2009, and Medtronic’s Quarterly Report on Form 10-Q for the fiscal quarter ended July 31, 2009, filed with the Commission on September 9, 2009;

     (2) Medtronic’s Current Reports on Form 8-K filed with the Commission on April 29, 2009, May 5, 2009, and September 1, 2009; and

     (3) The description of Common Stock and the associated Preferred Stock Purchase Rights contained in Amendment No. 2 to the Registration Statement on Form S-4 (No. 333-121239) filed with the Commission on January 10, 2005, under the heading “Description of Capital Stock” including any amendments or reports filed for the purpose of updating such description.

     All other documents subsequently filed (excluding those furnished) by Medtronic pursuant to Section 13(a), 13(c), 14 and 15(d) of the Exchange Act prior to the filing of a post-effective amendment to this Registration Statement that indicates that all securities offered have been sold or that deregisters all securities that remain unsold, shall be deemed to be incorporated by reference herein and to be part hereof from the date of filing of such documents.

     Any statement contained in a document incorporated or deemed incorporated herein by reference shall be deemed to be modified or superseded for the purpose of this Registration Statement to the extent that a statement contained herein or in any subsequently filed document which also is, or is deemed to be, incorporated herein by reference modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.

Item 8. Exhibits

Exhibit Number
4.1	Rights Agreement, dated as of October 26, 2000, between Medtronic, Inc. and Wells Fargo Bank Minnesota, N.A., including, as Exhibit A thereto, the form of Certificate of Designations, Preferences and Rights of Series A Junior Participating Preferred Shares of Medtronic, Inc. and, as Exhibit B thereto, the form of Preferred Stock Purchase Right Certificate, is incorporated herein by reference to Exhibit 4.1 to Medtronic, Inc.’s Form 8-A filed on November 3, 2000.
5.1	Opinion of Counsel regarding the legality of the securities being registered
10.1	Medtronic, Inc. 2008 Stock Award and Incentive Plan (As amended and restated effective August 27, 2009) (incorporated by reference to Appendix B to the Registrant’s 2009 Proxy Statement filed on July 17, 2009)
23.1	Consent of Counsel (included in Exhibit 5.1)
23.2	Consent of PricewaterhouseCoopers LLP, Independent Registered Public Accounting Firm
24.1	Power of Attorney

SIGNATURES

     Pursuant to the requirements of the Securities Act of 1933, Medtronic certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Minneapolis, Minnesota, on the 15th day of October, 2009.

MEDTRONIC, INC.
By:	/s/ William A. Hawkins
	William A. Hawkins
	Chairman and Chief Executive Officer

     Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed below by the following persons in the capacities and on the 15th day of October, 2009.

By:	/s/ William A. Hawkins
	William A. Hawkins
	Chairman and Chief Executive Officer (principal executive officer)
By:	/s/ Gary L. Ellis
	Gary L. Ellis
	Senior Vice President and Chief Financial Officer (principal financial and accounting officer)

Richard H. Anderson*	)
David L. Calhoun*	)
Victor J. Dzau, M.D.*	)
William A. Hawkins*	)
Shirley Ann Jackson, Ph.D.*	)
James T. Lenehan*	)	Directors
Denise M. O’Leary*	)
Kendall J. Powell*	)
Robert C. Pozen*	)
Jean-Pierre Rosso*	)
Jack W. Schuler*	)

* D. Cameron Findlay, by signing his name hereto, does hereby sign this document on behalf of each of the above named directors of the Registrant pursuant to powers of attorney duly executed by such persons on the 27th day of August, 2009.

By:	/s/ D. Cameron Findlay
	D. Cameron Findlay
	Senior Vice President, General Counsel and Corporate Secretary, as Attorney-in-Fact

EXHIBIT INDEX
TO
REGISTRATION STATEMENT ON FORM S-8

Exhibit Number		Description
	4.1	Rights Agreement, dated as of October 26, 2000, between Medtronic, Inc. and Wells Fargo Bank Minnesota, N.A., including, as Exhibit A thereto, the form of Certificate of Designations, Preferences and Rights of Series A Junior Participating Preferred Shares of Medtronic, Inc. and, as Exhibit B thereto, the form of Preferred Stock Purchase Right Certificate, is incorporated herein by reference to Exhibit 4.1 to Medtronic, Inc.’s Form 8-A filed on November 3, 2000.
	5.1	Opinion of Counsel regarding the legality of the securities being registered
	10.1	Medtronic, Inc. 2008 Stock Award and Incentive Plan (As amended and restated effective August 27, 2009) (incorporated by reference to Appendix B to the Registrant’s 2009 Proxy Statement filed on July 17, 2009)
	23.1	Consent of Counsel (included in Exhibit 5.1)
	23.2	Consent of PricewaterhouseCoopers LLP, Independent Registered Public Accounting Firm
	24.1	Power of Attorney

EX-5.1

EXHIBIT 5.1

October 15, 2009

Medtronic, Inc.
710 Medtronic Parkway
Minneapolis, Minnesota 55432

Ladies/Gentlemen:

I am principal legal counsel and assistant secretary of Medtronic, Inc., a Minnesota corporation (the “Company”), and I have advised the Company in connection with a registration statement on Form S-8 relating to the sale or issuance by the Company from time to time of up to an additional 50,000,000 shares (the “Shares”) of common stock, par value $.10, of the Company (“Common Stock”) issuable under the Medtronic, Inc. 2008 Stock Award and Incentive Plan (the “Plan”).

I have examined such documents and have reviewed such questions of law as I have considered necessary and appropriate for the purposes of my opinion set forth below.

In rendering my opinion set forth below, I have assumed the authenticity of all documents submitted to me as originals, the genuineness of all signatures and the conformity to authentic originals of all documents submitted to me as copies. I have also assumed the legal capacity for all purposes relevant hereto of all natural persons and, with respect to all parties to agreements or instruments relevant hereto other than the Company, that such parties had the requisite power and authority (corporate or otherwise) to execute, deliver and perform such agreements or instruments, that such agreements or instruments have been duly authorized by all requisite action (corporate or otherwise), executed and delivered by such parties and that such agreements or instruments are the valid, binding and enforceable obligations of such parties.

Based on the foregoing, I am of the opinion that the Shares have been duly authorized and, upon issuance, delivery and payment therefor in accordance with the terms of the Plan, and any relevant agreements thereunder, will be validly issued, fully paid and nonassessable.

I am admitted to the practice of law in the State of Minnesota, and the foregoing opinions are limited to the laws of that state and the federal laws of the United States of America.

I hereby consent to the filing of this opinion as an exhibit to the registration statement on Form S-8 of the Company relating to the Shares.

Very truly yours,

/s/ James N. Spolar James N. Spolar

Principal Legal Counsel and Assistant Secretary

EX-23.2

EXHIBIT 23.2

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in this Registration Statement on Form S-8 of our reports dated June 18, 2009 relating to the consolidated financial statements, financial statement schedule and the effectiveness of internal control over financial reporting, which appear in Medtronic, Inc.’s Annual Report on Form 10-K for the fiscal year ended April 24, 2009.

/s/ PricewaterhouseCoopers LLP

PricewaterhouseCoopers LLP

Minneapolis, Minnesota

October 15, 2009

EX-24.1

EXHIBIT 24.1

POWER OF ATTORNEY

     KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints WILLIAM A. HAWKINS and D. CAMERON FINDLAY, or either of them severally, his or her true and lawful attorney-in-fact with full power of substitution and resubstitution to sign in his or her name, place and stead, in any and all capacities, to do any and all things and execute any and all instruments that such attorney may deem necessary or advisable under the Securities Act of 1933, and any rules, regulations and requirements of the Securities and Exchange Commission, including specifically, but without limiting the generality of the foregoing, the power and authority to sign his or her name in his or her respective capacity as a member of the Board of Directors or officer of the Registrant, a Registration Statement on Form S-8 relating to the Medtronic, Inc. 2008 Stock Award and Incentive Plan, any and all amendments (including post-effective amendments) to such Registration Statement and any other documents filed with the Securities and Exchange Commission, as fully for all intents and purposes as he or she might or could do in person, and hereby ratifies and confirms all said attorneys-in-fact and agents, each acting alone, and his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

          IN WITNESS WHEREOF, each of the undersigned has executed this Power of Attorney as of the 27th day of August, 2009.

/s/ Richard H. Anderson Richard H. Anderson	/s/ Denise M. O’Leary  Denise M. O’Leary
/s/ David L. Calhoun David L. Calhoun	/s/ Kendall J. Powell  Kendall J. Powell
/s/ Victor J. Dzau, M.D. Victor J. Dzau, M.D.	/s/ Robert C. Pozen  Robert C. Pozen
/s/ William A. Hawkins William A. Hawkins	/s/ Jean-Pierre Rosso  Jean-Pierre Rosso
/s/ Shirley Ann Jackson, Ph.D. Shirley Ann Jackson, Ph.D.	/s/ Jack W. Schuler  Jack W. Schuler
/s/ James T. Lenehan James T. Lenehan